RxNorm Semantic Concepts Index - 613
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "613".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 613 | Aluminium hydroxide gel | British preferred term (PTGB) | YES | |
| Concept ID (RxCUI): 613 | Aluminium hydroxide gel | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 613 | Aluminium hydroxide gel | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 613 | Aluminium hydroxide gel | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6130 | Ketamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 6130 | Ketamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6130 | Ketamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6130 | Ketamine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6130 | Ketamine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6131 | Ketanserin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6131 | Ketanserin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6131 | Ketanserin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6131 | Ketanserin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6131 | Ketanserin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 61326 | Caffeate o-methyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 61326 | Caffeate o-methyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6133 | Oxo-acid-lyase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6133 | Oxo-acid-lyase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 613324 | Arranon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 613391 | prasugrel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 613391 | prasugrel | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 613391 | prasugrel | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 613391 | prasugrel | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 613391 | prasugrel | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6135 | Ketoconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 6135 | Ketoconazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6135 | Ketoconazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6135 | Ketoconazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6135 | Ketoconazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 613503 | CD138 - cluster of differentiation 138 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 61356 | American wormseed oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 61356 | American wormseed oil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 61356 | American wormseed oil | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 61381 | olanzapine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 61381 | olanzapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 61381 | olanzapine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 61381 | olanzapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 61381 | olanzapine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 61381 | olanzapine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 613876 | Nevanac | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 61392 | Lipid-A 4'-kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 61392 | Lipid-A 4'-kinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 61392 | Lipid-A 4'-kinase | Full form of descriptor (FN) | NO |